Search results
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 2 days ago"FDA approves AstraZeneca’s Farxiga for paediatric T2D patients" was originally created and...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via Yahoo News· 6 days agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
Supreme Court rejects challenge to FDA's approval of mifepristone
WLRN Miami· 1 day agoThe court’s decision also avoided, at least for now, a challenge to the entire structure of the FDA...
Supreme Court Decides Food and Drug Administration v. Alliance for Hippocratic Medicine | JD Supra
JD Supra· 14 hours agoIn 2000, the federal Food and Drug Administration (FDA) approved a new drug application for mifepristone, a drug which is used for, among other things, ...
SCOTUS ruling on mifepristone could have lasting impact on FDA regulation: Experts
ABC7 News· 11 hours agoThe court unanimously struck down a lawsuit seeking to restrict nationwide access to mifepristone,...
Why FDA Panel Rejected MDMA Therapy—And What’s Next For Psychedelic Medicine
Forbes· 1 day agoThe FDA has previously acknowledged its therapeutic potential, granting a new drug application,...
FDA Approves Expansion of Treatment Area for AK Treatment
Medscape· 4 days agoApproval was based on a phase 3, open-label study of adults with AKs.
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance· 1 day agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
Opinion | Trump just dodged a major Supreme Court ruling — for now
MSNBC· 45 minutes agoThe first case began when the Alliance Defending Freedom, a leading litigator in the conservative...
Abortion pill’s hazy legal future
Politico· 5 hours agoRobert Califf kept his reaction short and to the point. “We are pleased with the Supreme Court’s decision,” he said. “Under that decision, mifepristone remains available under the conditions ...
